secretory IgA
[대역어] 분비형 IgA
[용어속성] Term
[용어속성] Term
Inhalable dry powder mRNA vaccines based on extracellular vesicles
Research article
[키워드] Bioavailability
Bronchiole
carriers
circumvent
COVID-19
death
disease
distribution
dry powder inhalation
elicited
exhibited
Exosome
Exosomes
extracellular vesicle
Extracellular vesicles
functional
greater
IgG
illness
Immunoglobulin
Inhaled
limitation
limitations
Liposome
lung
mRNA
mRNA vaccine
NHPs
nonhuman primate
Protein
remained
respiratory
Respiratory Coronavirus
response
rodent
SARS-CoV-2
secretory IgA
SIgA
Spike protein
stability
Therapeutics
Vaccine
[DOI] 10.1016/j.matt.2022.06.012 [Article Type] Research article
[DOI] 10.1016/j.matt.2022.06.012 [Article Type] Research article
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection
Review
[키워드] adopted
anti-SARS-CoV-2
anti-SARS-CoV-2 antibodies
antigen-based immunoassays
antigenic
appear
asymptomatic individual
Blood
can be used
China
COVID-19
CRISPR
death
detect
Diagnosis
diagnostic
effective
ELISA
globe
Health care system
helping
immune response
immunoassays
increase
infected with SARS-CoV-2
Infection
Laboratory
molecular
mucosal
mucosal surfaces
nasal
nasopharyngeal
Next-generation sequencing
NGS
Non-invasive
Oropharyngeal
oropharyngeal swabs
palindromic repeat
PCR
recent
replicating virus
RNA
RT-PCR
Saliva
SARS-CoV-2
SARS-COV-2 infection
secretory IgA
Sensitivity and specificity
Spike protein
spike protein.
Spread
Stress
subject
the SARS-CoV-2
Vaccine
viral antigens
Viral RNA
virus
virus entry
widespread
[DOI] 10.3390/microorganisms10061193 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/microorganisms10061193 PMC 바로가기 [Article Type] Review
Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
재조합 RBD 백신의 비강내 투여는 오미크론이 포함된 SARS-CoV-2 변이체에 대한 장기 면역을 유도합니다
Article
Published on
Journal: Signal Transduction and Targeted Therapy
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료제,
Journal: Signal Transduction and Targeted Therapy
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
administration
booster
Cell
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
COVID-19
deficiency
demonstrated
Economy
effective vaccine
Emergency
global health
Health
IgG antibody
immune response
immune responses
Immunity
immunization
induce
intramuscularly
intranasal
Local
long-lasting
lung
lymph nodes
memory T cell
memory T cells
mice
Migration
mucosal
mutant strain
Neutralizing
omicron
Omicron variants
outbreak
persistence
proliferation
protective immunity
RBD
required
respiratory
robust
SARS-CoV-2
SARS-CoV-2 variant
secretory IgA
sera
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
Strains
Strong
suggested
systemically
T cells
T-cell
threat
Vaccine
vaccine candidate
Vaccines
variant
variants
waning immunity
wild-type
[DOI] 10.1038/s41392-022-01002-1 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41392-022-01002-1 PMC 바로가기 [Article Type] Article
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2
레플리콘 기반 mRNA 백신 후보의 박테리아 지원 경구 전달은 조상 및 델타 변이형 SARS-CoV-2로부터 보호
Article
Published on
Journal: Molecular therapy : the journal of the American So
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제,
Journal: Molecular therapy : the journal of the American So
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
alphaviruses
antibody
antigenic diversity
B.1.617.2
Bacteria
Cellular immune response
cellular immune responses
clade
contributed
contributing to
Coronavirus-2
COVID-19
cross-protective
domain
Efficacy
epitope
Epitopes
Evolution
feasible
forest
gene delivery
hamster
hamsters
heptad repeat
immune responses
immunization
immunized
immunized mice
Immunoglobulin
lung
Lungs
mass vaccination
membrane protein
mRNA
mRNA vaccine
mucosal
mucosal vaccine
NAbs
nasal
Nasal cavity
Neutralizing antibodies
neutralizing antibody
non-structural protein
nsp13
offer
oral
Oral Immunization
oral route
Pneumonia
principle
PROTECT
provide
RBD
Receptor binding domain
recorded
replicon-based
respiratory
Salmonella
Salmonella-mediated
SARS-CoV-2
secretory IgA
SIgA
the vaccine
vaccination
Vaccine
vaccine efficacy
variant
variants
variants.
Viral
viral replication
virus
[DOI] 10.1016/j.ymthe.2022.01.042 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ymthe.2022.01.042 PMC 바로가기 [Article Type] Article
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time
Research Article
[키워드] Analysis
antibody
binding
Care
controls
COVID-19
COVID-19 illness
COVID-19 sample
dominant
Donor
Endpoint
exhibited
exhibiting
human milk
IgA
IgA antibody
IgA titer
IgG response
immunization
Infant
Infants
infected with SARS-CoV-2
Infection
Level
mucosal
neutralization
neutralization capacity
Neutralizing
Participants
positive
positively correlated
potential mechanism
Prevalence
PROTECT
Protective
public health
reported
robust
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2-specific antibody
secretory IgA
shown
subset
tested
therapeutic
VSV
[DOI] 10.1371/journal.pone.0249723 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0249723 PMC 바로가기 [Article Type] Research Article
The seven constitutive respiratory defense barriers against SARS-CoV-2 infection
SARS-COV-2 감염에 대한 7 가지 구성 호흡기 방어 장벽
Review
[키워드] activate
adaptive
Adaptive immune response
adaptive immune responses
airway
alveoli
antibodies
antimicrobial peptide
antimicrobial peptides
Antiviral
antiviral activity
cascade
Cell
clearance
component
Defense
Defensins and lactoferrin
elicit
ENhance
epithelial cell
Epithelial cell interferons
epithelial cells
functions
Gas exchange
IgA antibodies
immune
Immune cell
immune cells
immune responses
immunomodulatory molecule
Infection
infectious agents
Inhaled
inhibit
inhibit SARS-CoV-2
Innate immunity
interferons
Invasion
lactoferrin
Local
luminal
luminal surface
mechanisms
microbiota
modulate
Mucociliary clearance
Mucus
noxious
overcome
Particles
pathogen
peptides
phagocytes
receptor
receptors
regulate
respiratory
respiratory epithelial cells
respiratory tract
Respiratory tract microbiota
respiratory viruses
SARS-CoV-2
SARS-COV-2 infection
secretory
secretory IgA
Seven
subject
surface tension
Surfactant proteins
tension
these cell
These cells
Viral
virus
[DOI] 10.1590/0037-8682-0461-2021 PMC 바로가기 [Article Type] Review
[DOI] 10.1590/0037-8682-0461-2021 PMC 바로가기 [Article Type] Review
Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination
Report
[키워드] Abstract
Affect
anti-RBD
Anti-spike
antibody
antibody production
Antibody titer
BNT162b2
breastmilk
breastmilk T cells
circulating
Combination
Concentration
controls
COVID-19
cumulative
determine
effective
evaluated
Frequency
functional
IgA
IgG
immune protection
immune response
immune transfer
induce
lactating women
mammary
maternal vaccination
memory B cell
memory B cells
milk-transferred SARS-CoV-2 protection
milk-transferred spike-reactive T cells
Moderna
mRNA vaccination
mRNA vaccine
mRNA-1273 vaccine
mucosa
neutralization capacity
neutralize
Neutralizing
neutralizing capacity
occur
Pfizer
plasmablasts
Protective
RBD
SARS-CoV-2
SARS-CoV-2 spike protein
secretory
secretory IgA
SIgA
spike SIgA
transfer
transferred
vaccination
[DOI] 10.1016/j.xcrm.2021.100468 PMC 바로가기 [Article Type] Report
[DOI] 10.1016/j.xcrm.2021.100468 PMC 바로가기 [Article Type] Report
Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2
SARS-CoV-2에 감염된 산모에게서 태어난 신생아의 면역 반응
Observational Study
[키워드] 48 hour
48 hours
age
antibody
antibody production
arbitrary unit
association
Birth
breastmilk
children
Clinical outcome
cohort study
enrolled
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
evaluated
explain
exposure
exposure to
finding
Follow-up
gestational age
IgA
IgA antibodies
IgA antibody
IgG antibodies
IgM antibodies
IgM antibody
immune complex
Immune complexes
immune response
immune responses
immune system
Importance
in utero
Infant
Infants
infected with SARS-CoV-2
Infection
infection with SARS-CoV-2
information
investigated
IQR
Italy
life
male
Maternal
maternal age
measure
mother
mucosal
mucosal immune
Neonatal
Neonate
Newborn
objective
occurred
offspring
participant
parturition
passive immunity
Point
positive
Pregnancy
pregnant women
prospective cohort study
PROTECT
provided
Receptor binding
Receptor binding domain
Relevance
response
Result
Rome
Saliva
salivary
SARS-CoV-2
SARS-CoV-2 IgG
SARS-COV-2 infection
SARS-CoV-2 spike
secretory IgA
serum
setting
significantly higher
significantly increased
specific antibodies
specific antibody
specific IgG antibodies
spike-specific antibodies
Spike-specific antibody
spike-specific IgG
stimulate
systemic immune response
systemic immune responses
tested
transfer
Transmission
Umberto
vertical transmission
vertical virus transmission
virus
Virus spike
virus transmission
[DOI] 10.1001/jamanetworkopen.2021.32563 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1001/jamanetworkopen.2021.32563 PMC 바로가기 [Article Type] Observational Study
Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
Microbiology
[키워드] analyzed
association
Bacteria
clinical disease
component
controls
coronavirus SARS-CoV-2
correlated
COVID-19
COVID-19 disease
COVID-19 patient
COVID-19 patients
determine
Dysbiosis
Evidence
fungi
GM-CSF
Gut
identify
IgA response
IL-17
immune response
Immunoglobulin
Inflammation
Inflammatory cytokines
Local
local immune response
local inflammation
marker
microbial community
Microbiome
mucosal
oral
Oral microbiome
other diseases
pandemic
parameter
PCR
primary site
pro-inflammatory cytokine
progression
Protective
quantified
Replication
respiratory virus
response
SARS-COV-2 infection
secretory IgA
shown
significantly
subjects
susceptibility
symptom severity
symptomatic patient
systemic diseases
the SARS-CoV-2
therapy
TNFα
to define
Vaccine development
virus
virus infection
virus replication
viruses
WGS
[DOI] 10.3389/fmicb.2021.687513 PMC 바로가기 [Article Type] Microbiology
[DOI] 10.3389/fmicb.2021.687513 PMC 바로가기 [Article Type] Microbiology